Therapeutic potential of allosteric HECT E3 ligase inhibition
Cell · 2025-05 · 188 (10) · 2603-2620.e18
DOI: 10.1016/j.cell.2025.03.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-05. Verfasst von Alexander M K Rothman und 38 weiteren Autor:innen. Beteiligte Einrichtung: University of Sheffield, Sheffield, UK; Novartis BioMedical Research (NBR), Cambridge, MA, USA. Electronic address: a.rothman@sheffield.ac.uk. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Israel Cancer Research Fund, Academy of Medical Sciences.
Abstract (Originalsprache)
Targeting ubiquitin E3 ligases is therapeutically attractive; however, the absence of an active-site pocket impedes computational approaches for identifying inhibitors. In a large, unbiased biochemical screen, we discover inhibitors that bind a cryptic cavity distant from the catalytic cysteine of the homologous to E6-associated protein C terminus domain (HECT) E3 ligase, SMAD ubiquitin regulatory factor 1 (SMURF1). Structural and biochemical analyses and engineered escape mutants revealed that these inhibitors restrict an essential catalytic motion by extending an α helix over a conserved glycine hinge. SMURF1 levels are increased in pulmonary arterial hypertension (PAH), a disease caused by mutation of bone morphogenetic protein receptor-2 (BMPR2). We demonstrated that SMURF1 inhibition prevented BMPR2 ubiquitylation, normalized bone morphogenetic protein (BMP) signaling, restored pulmonary vascular cell homeostasis, and reversed pathology in established experimental PAH. Leveraging this deep mechanistic understanding, we undertook an in silico machine-learning-based screen to identify inhibitors of the prototypic HECT E6AP and confirmed glycine-hinge-dependent allosteric activity in vitro. Inhibiting HECTs and other glycine-hinge proteins opens a new druggable space.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Sheffield, Sheffield, UK; Novartis BioMedical Research (NBR), Cambridge, MA, USA. Electronic address: a.rothman@sheffield.ac.uk.
- School of Neurobiology, Biochemistry and Biophysics, The Life Sciences Faculty, Tel Aviv University, Tel Aviv, Israel.
- Novartis BioMedical Research (NBR), Basel, Switzerland.
- Novartis BioMedical Research (NBR), Cambridge, MA, USA.
- Novartis Institutes for BioMedical Research (NIBR), Horsham, UK.
- School of Neurobiology, Biochemistry and Biophysics, The Life Sciences Faculty, Tel Aviv University, Tel Aviv, Israel; Novartis BioMedical Research (NBR), Basel, Switzerland.
Förderung
- Israel Science Foundation
- Israel Cancer Research Fund
- Academy of Medical Sciences
- Wellcome Trust
- National Institute for Health and Care Research
- Ministry of Science and Technology, Israel
- NIHR Sheffield Biomedical Research Centre
- National Institute of Biological Resources
Zitieren
APA
Rothman, A. M. K., Florentin, A., Zink, F., Quigley, C., Bonneau, O., Hemmig, R., Hachey, A., Rejtar, T., Thaker, M., Jain, R., Huang, S. M., Sutton, D., Roger, J., Zhang, J. H., Weiler, S., Cotesta, S., Ottl, J., Srivastava, S., Kordonsky, A., …, & Rowlands, D. J. (2025). Therapeutic potential of allosteric HECT E3 ligase inhibition. Cell, 188(10), 2603-2620.e18. https://doi.org/10.1016/j.cell.2025.03.001
Vancouver
Rothman AMK, Florentin A, Zink F, Quigley C, Bonneau O, Hemmig R, et al. Therapeutic potential of allosteric HECT E3 ligase inhibition. Cell. 2025;188(10):2603-2620.e18. doi:10.1016/j.cell.2025.03.001
BibTeX
@article{Rothman2025,
author = {Rothman, Alexander M K and Florentin, Amir and Zink, Florence and Quigley, Catherine and Bonneau, Olivier and Hemmig, Rene and Hachey, Amanda and Rejtar, Tomas and Thaker, Maulik and Jain, Rishi and Huang, Shih-Min and Sutton, Daniel and Roger, Jan and Zhang, Ji-Hu and Weiler, Sven and Cotesta, Simona and Ottl, Johannes and Srivastava, Salil and Kordonsky, Alina and Avishid, Reut and Yariv, Elon and Rathi, Ritu and Khvalevsky, Oshrit and Troxler, Thomas and Binmahfooz, Sarah K and Kleifeld, Oded and Morrell, Nicholas W and Humbert, Marc and Thomas, Matthew J and Jarai, Gabor and Beckwith, Rohan E J and Cobb, Jennifer S and Smith, Nichola and Ostermann, Nils and Tallarico, John and Shaw, Duncan and Guth-Gundel, Sabine and Prag, Gali and Rowlands, David J},
title = {Therapeutic potential of allosteric HECT E3 ligase inhibition},
journal = {Cell},
year = {2025},
volume = {188},
number = {10},
pages = {2603--2620.e18},
doi = {10.1016/j.cell.2025.03.001}
}
EUVIMED